FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

21705311000001107: Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 09-Jan 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
71863001000001116 Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
80034201000001112 Komboglyze 2.5mg/850mg tablets (AstraZeneca UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Is a Saxagliptin 2.5mg / Metformin 850mg tablets true Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has active ingredient Metformin hydrochloride true Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has active ingredient Saxagliptin true Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has specific active ingredient Metformin hydrochloride true Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has specific active ingredient Saxagliptin hydrochloride false Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Saxagliptin true Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Is a Komboglyze true Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has basis of strength substance Saxagliptin true Inferred relationship Existential restriction modifier
Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Has specific active ingredient Saxagliptin hydrochloride true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) 56 tablet 7 x 8 tablets Has AMP True Komboglyze 2.5mg/850mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start